Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X. J Hepatocell Carcinoma. 2024;11:175–189.

The authors have advised that they neglected to include a funding statement on page 187 of the published paper. The funding statement should read as follows.

FundingThis work was supported by the National Natural Science Foundation of China (82330061).

The authors apologize for any inconvenience caused to the readers.

Read the original article


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

留言 (0)

沒有登入
gif